KROS vs TMUS · rev $32.0K vs P/E 19, rev $22.79B
Keros Therapeutics Inc (KROS) versus T-Mobile US Inc (TMUS) — a side-by-side from cached financials, not a winner call.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
T-Mobile US Inc (TMUS) is a telecom services company listed on NASDAQ. It is led by Mike Sievert.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
Latest reported TMUS revenue for 2026-06-30 was $22.79B. Net income was $3.24B. Revenue was down 1.4% from 2026-03-31 to 2026-06-30. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
KROS currently screens at market cap $208.8M. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
Not investment advice. Open the KROS and TMUS stock pages for the full models.
Not investment advice.